99 related articles for article (PubMed ID: 16984387)
41. Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia.
Pakakasama S; Kajanachumpol S; Kanjanapongkul S; Sirachainan N; Meekaewkunchorn A; Ningsanond V; Hongeng S
Int J Lab Hematol; 2008 Aug; 30(4):286-91. PubMed ID: 18665825
[TBL] [Abstract][Full Text] [Related]
42. Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
Ryan J; Quinn F; Meunier A; Boublikova L; Crampe M; Tewari P; O'Marcaigh A; Stallings R; Neat M; O'Meara A; Breatnach F; McCann S; Browne P; Smith O; Lawler M
Br J Haematol; 2009 Jan; 144(1):107-15. PubMed ID: 19016726
[TBL] [Abstract][Full Text] [Related]
43. DHPLC based fraction collection of TCR-gamma rearrangements in childhood ALL: direct sequencing of products amplified by a single or a multiplex PCR approach.
Zur Stadt U; Isbarn H; Schneppenheim R; Kabisch H
Int J Oncol; 2005 Aug; 27(2):547-52. PubMed ID: 16010438
[TBL] [Abstract][Full Text] [Related]
44. Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene.
Sausville JE; Salloum RG; Sorbara L; Kingma DW; Raffeld M; Kreitman RJ; Imus PD; Venzon D; Stetler-Stevenson M
Am J Clin Pathol; 2003 Feb; 119(2):213-7. PubMed ID: 12579991
[TBL] [Abstract][Full Text] [Related]
45. Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease.
van der Velden VH; de Bie M; van Wering ER; van Dongen JJ
Haematologica; 2006 May; 91(5):679-82. PubMed ID: 16627258
[TBL] [Abstract][Full Text] [Related]
46. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
[TBL] [Abstract][Full Text] [Related]
47. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
Schwarz AK; Stanulla M; Cario G; Flohr T; Sutton R; Möricke A; Anker P; Stroun M; Welte K; Bartram CR; Schrappe M; Schrauder A
Ann Hematol; 2009 Sep; 88(9):897-905. PubMed ID: 19165483
[TBL] [Abstract][Full Text] [Related]
48. ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.
Zen PR; Capra ME; Silla LM; Loss JF; Fernandes MS; Jacques SM; Paskulin GA
Cancer Genet Cytogenet; 2009 Jan; 188(2):112-7. PubMed ID: 19100516
[TBL] [Abstract][Full Text] [Related]
49. Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method.
Shi Y; Li LZ; Sun JZ; Zhang T; Peng J; Xu CG
Ann Hematol; 2008 Jan; 87(1):35-41. PubMed ID: 17846772
[TBL] [Abstract][Full Text] [Related]
50. Detection of recurrent translocations using real time PCR; assessment of the technique for diagnosis and detection of minimal residual disease.
Gabert J
Haematologica; 1999 Jun; 84 Suppl EHA-4():107-9. PubMed ID: 10907485
[No Abstract] [Full Text] [Related]
51. RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.
Podgornik H; Debeljak M; Zontar D; Cernelc P; Prestor VV; Jazbec J
Cancer Genet Cytogenet; 2007 Oct; 178(1):77-81. PubMed ID: 17889714
[TBL] [Abstract][Full Text] [Related]
52. Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR.
Itälä M; Huhtinen AR; Juvonen V; Kairisto V; Pelliniemi TT; Penttilä TL; Rauhala A; Tienhaara A; Remes K
Eur J Haematol; 2008 Aug; 81(2):100-6. PubMed ID: 18410542
[TBL] [Abstract][Full Text] [Related]
53. Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia.
Thörn I; Botling J; Hermansson M; Lönnerholm G; Sundström C; Rosenquist R; Barbany G
Leuk Res; 2009 Aug; 33(8):1047-54. PubMed ID: 19157547
[TBL] [Abstract][Full Text] [Related]
54. Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course.
Taira C; Matsuda K; Kamijyo Y; Sakashita K; Ishida F; Kumagai T; Yamauchi K; Okumura N; Honda T
Clin Chim Acta; 2011 Jan; 412(1-2):53-8. PubMed ID: 20849840
[TBL] [Abstract][Full Text] [Related]
55. TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia.
Kang HJ; Oh Y; Chun SM; Seo YJ; Shin HY; Kim CW; Ahn HS; Han BD
Mol Cell Probes; 2008 Jun; 22(3):193-200. PubMed ID: 18385010
[TBL] [Abstract][Full Text] [Related]
56. The detection and significance of minimal residual disease in acute and chronic leukemia.
Chung NG; Buxhofer-Ausch V; Radich JP
Tissue Antigens; 2006 Nov; 68(5):371-85. PubMed ID: 17092250
[TBL] [Abstract][Full Text] [Related]
57. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
Chen JS; Hsiao CC; Sheen JM; Cheng CN
Leuk Res; 2007 Oct; 31(10):1351-7. PubMed ID: 17445885
[TBL] [Abstract][Full Text] [Related]
58. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
[TBL] [Abstract][Full Text] [Related]
59. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
Barragan E; Pajuelo JC; Ballester S; Fuster O; Cervera J; Moscardo F; Senent L; Such E; Sanz MA; Bolufer P
Clin Chim Acta; 2008 Sep; 395(1-2):120-3. PubMed ID: 18590714
[TBL] [Abstract][Full Text] [Related]
60. AML1-ETO positive AML: first report from India.
Dutta P; Hasan SK; Sazawal S; Kumar B; Bhattacharyya J; Jain M; Tyagi S; Kumar R; Pati HP; Saxena R
Indian J Pathol Microbiol; 2007 Jul; 50(3):652-4. PubMed ID: 17883173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
